Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Cancer Research
|
April 15, 1994
Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation
G Raschella, A Romeo, A Negroni, et al.
Anticancer Research
|
September 1, 1995
D-CECaT as preoperative chemotherapy for unresectable neuroblastoma in children over one year of age
A Donfrancesco, G Deb, C Dominici, et al.
Minerva Chirurgica
|
March 1, 1997
[Pre- and postoperative color Doppler ultrasonography of myocutaneous flaps in reconstructive surgery of the breast]
A Pacifici, R Cirocchi, F O Flamini, et al.
Anticancer Research
|
November 1, 1993
Peripheral blood stem cells in children with solid tumors. Part I. Feasibility and application
G Deb, C Dominici, A Angioni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1991
N-myc genomic content and DNA ploidy in stage IVS neuroblastoma
J Bourhis, C Dominici, H McDowell, et al.
Journal of Neuro-Oncology
|
January 1, 1997
Immunohistochemical detection of p140trkA and p75LNGFR neurotrophin receptors in neuroblastoma
C Dominici, M R Nicotra, S Alemà, et al.
Leukemia
|
August 1, 2012
Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression
S Cialfi, R Palermo, S Manca, et al.
Progress in Clinical and Biological Research
|
January 1, 1991
High-dose carboplatin with etoposide (JET regimen) in children with advanced neuroblastoma
M A Castello, A Donfrancesco, A Clerico, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
Immunohistochemical detection of high-affinity nerve growth factor receptor in neuroblastoma
C Dominici, M R Nicotra, G Digiesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 12, 2013
Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma
L Calafiore, L Amoroso, O Della Casa Alberighi, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Cancer Research
|
April 15, 1994
Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation
G Raschella, A Romeo, A Negroni, et al.
Anticancer Research
|
September 1, 1995
D-CECaT as preoperative chemotherapy for unresectable neuroblastoma in children over one year of age
A Donfrancesco, G Deb, C Dominici, et al.
Minerva Chirurgica
|
March 1, 1997
[Pre- and postoperative color Doppler ultrasonography of myocutaneous flaps in reconstructive surgery of the breast]
A Pacifici, R Cirocchi, F O Flamini, et al.
Anticancer Research
|
November 1, 1993
Peripheral blood stem cells in children with solid tumors. Part I. Feasibility and application
G Deb, C Dominici, A Angioni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1991
N-myc genomic content and DNA ploidy in stage IVS neuroblastoma
J Bourhis, C Dominici, H McDowell, et al.
Journal of Neuro-Oncology
|
January 1, 1997
Immunohistochemical detection of p140trkA and p75LNGFR neurotrophin receptors in neuroblastoma
C Dominici, M R Nicotra, S Alemà, et al.
Leukemia
|
August 1, 2012
Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression
S Cialfi, R Palermo, S Manca, et al.
Progress in Clinical and Biological Research
|
January 1, 1991
High-dose carboplatin with etoposide (JET regimen) in children with advanced neuroblastoma
M A Castello, A Donfrancesco, A Clerico, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
Immunohistochemical detection of high-affinity nerve growth factor receptor in neuroblastoma
C Dominici, M R Nicotra, G Digiesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 12, 2013
Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma
L Calafiore, L Amoroso, O Della Casa Alberighi, et al.
Page
of 9